BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Amgen
National Cancer Center Hospital East
University of Washington
Stanford University
Freenome Holdings Inc.
I-Mab Biopharma US Limited
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Abramson Cancer Center at Penn Medicine
Hoffmann-La Roche
Imugene Limited
Boehringer Ingelheim
Wake Forest University Health Sciences
NantBioScience, Inc.
Five Prime Therapeutics, Inc.
Massachusetts General Hospital
Fengh Medical Co., Ltd.
InnoPharmax Inc.
Sumitomo Pharma America, Inc.
Revolution Medicines, Inc.
Dana-Farber Cancer Institute
Indiana University
Abramson Cancer Center at Penn Medicine
Daiichi Sankyo
Dana-Farber Cancer Institute
Taiho Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Cedars-Sinai Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Texas Southwestern Medical Center
Isofol Medical AB
Abramson Cancer Center at Penn Medicine
University of Maryland, Baltimore
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Wake Forest University Health Sciences
Takeda
Novartis
Rigshospitalet, Denmark
Yale University
Herlev Hospital
Dana-Farber Cancer Institute
Exact Sciences Corporation
Pfizer
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
M.D. Anderson Cancer Center